前往化源商城

地拉考昔

更新时间:2025-08-23 17:53:54 采购访问:99次

常用名 地拉考昔 CAS号 169590-41-4
价格 ¥1166.0/100mg ¥506.0/25mg 纯度 98.0%
备货期 2天 库存 询单
 产品详情(用途,包装等)
用途:
Deracoxib, a selective cyclooxygenase-2 inhibitor, is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID). IC50 Value: 70 to 150 uM(inhibition of 3 osteosarcoma cell lines) [1]Target: COXin vitro: Concentration of deracoxib required for 50% inhibition of cell viability (IC50) was reached in all 3 osteosarcoma cell lines and ranged from 70 to 150 microM, whereas the IC50 for piroxicam was only reached in the POS cell line at 500 microM. Neither deracoxib nor piroxicam induced sufficient toxicity in fibroblasts to reach an IC50. Exposure of osteosarcoma cells to cytotoxic concentrations of deracoxib and piroxicam did not result in DNA fragmentation [1]. Concomitant treatment of cells with piroxicam and deracoxib resulted in significant induction of apoptosis at lower concentrations and accumulation of cells in the G /G phase. Significant cytotoxic effects exhibited by the combination of piroxicam and deracoxib against canine mammary carcinoma cells in vitro suggest an attractive approach for the treatment of canine mammary carcinoma [2].in vivo: Perioperative administration of deracoxib to dogs at 1-2 mg/kg/day for 3 days significantly improves analgesia in the postoperative surgical period after soft tissue surgery [3]. Dogs were treated PO with deracoxib at a dosage of 3 mg/kg/d (1.36 mg/lb/d) as a single-agent treatment for TCC. Tumor response was assessed via radiography, abdominal ultrasonography, and ultrasonographic mapping of urinary bladder masses. Toxic effects of deracoxib administration in dogs were assessed through clinical observations and hematologic and biochemical analyses. 24 dogs for which tumor response was assessed, 4 (17%) had partial remission, 17 (71%) had stable disease, and 3 (13%) had progressive disease; initial response could not be assessed in 2 of 26 dogs. The median survival time was 323 days. Median time to progressive disease was 133 days. Renal, hepatic, and gastrointestinal abnormalities attributed to deracoxib administration were noted in 4% (1/26), 4% (1/26), and 19% (5/26) of dogs, respectively [4].
物理化学性质:
CAS号:169590-41-4
常用中文名:地拉考昔
常用英文名:deracoxib
分子式:C17H14F3N3O3S
分子量:397.372
密度:1.5±0.1 g/cm3
沸点:575.5±60.0 °C at 760 mmHg
熔点:N/A
闪点:301.9±32.9 °C
储存条件:-20℃

供应商信息

上海吉至生化科技有限公司 认证供应商

认证状态:已认证供应商
商品数:50230件
电话:021-57481218
地址:奉贤区望园南路1588弄1号1710
地区: 上海市 上海市 奉贤区
联系人:刘佳
联系人电话:18116092098
邮件:2130147988@qq.com
网址:http://www.acmec-e.com/
主要市场:
年贸易额:
外贸占销售比例:
主要合作伙伴:
上海吉至生化科技有限公司是一家致力于生化试剂与生命科学领域产品的研发与销售的综合性试剂公司。“让每个实验员都能享受实验成功的乐趣”是我们公司的愿景。

公司由业内资深人士组建而成,有独立的研发、生产、质检、销售、仓库、办公基地,吸纳国内一流大学和知名科研机构优秀人才,拥有良好的专业背景与实践经验,庞大的数据网络体系,与国内外先进科研机构保持密切联系,跻身国际前列水平。

公司总部位于中国上海,并在上海,河北设有大型物流仓库,货品数量多达40000种,采取现代化的仓储先进的物流体系,可以最大限度的保证了试剂的安全、迅速及时的送达到客户手中。

公司自成立以来,一直把产品质量视为公司参与市场竞争的核心,正是这个成功的定位和员工强烈的产品质量意识,使我们成为专业的化学试剂供应商。
公司根据产品质量要求,建立了严密的质量检验体系。公司对与产品质量有关的所有环节进行严格控制与管理,建立了科学的检验标准,并对检验指标进行了量化,责任到人,确保公司保持稳定合格的产品。
公司从原材料严格把关,所有物料必须符合国家标准,建立严格的产品工艺指标。
公司有定期的员工质量培训,讲解质量管理的新知识、新信息,树立每一个员工的质量意识,规范自己行为,做到精益求精。质检部门建立了规范的检验规程,具备先进完善的检测设备和手段,并严格按照规程检验。
积极倾听客户需求;精心构建产品质量;真诚提供满意服务; 时刻铭记为客户服务是我们存在的唯一理由。
我们围绕客户的需求持续创新,与合作伙伴开放合作。我们致力于为科研工作者提供有竞争力的综合解决方案和服务,持续提升客户体验,为客户创造最大价值。

创业是一种情怀,ACMEC是一个品牌,吉至是一种信念,我们很极致。
推荐生产厂家/供应商:我要出现这里





查看所有供应商和价格请点击:

地拉考昔生产厂家


参考价格:¥390/25mg
其他供应商价格:
2024-07-15 地拉考昔
价格:需询单
2022-11-29 Deracoxib
价格:¥需询单
2021-02-06 Deracoxib
价格:¥9589.0
2024-03-12 地拉考昔
价格:¥41.9

查看所有价格,请点击地拉考昔价格